Cas:37464-90-7 1,4-Dimethoxy-6-tetralone manufacturer & supplier

Chemical Name:1,4-Dimethoxy-6-tetralone

CAS.NO:37464-90-7

Synonyms:5,8-dimethoxy-3,4-dihydro-1H-naphthalen-2-one

Molecular Formula:C₁₂H₁₄O₃

Molecular Weight:206.23800

HS Code:2914509090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:388.2ºC at 760mmHg

Density:1.14g/cm3

Index of Refraction:1.537

PSA:35.53000

Exact Mass:206.09400

LogP:1.76160

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5,8-dimethoxy-3,4-dihydro-1H-naphthalen-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5,8-dimethoxy-3,4-dihydro-1H-naphthalen-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5,8-dimethoxy-3,4-dihydro-1H-naphthalen-2-one Use and application,5,8-dimethoxy-3,4-dihydro-1H-naphthalen-2-one technical grade,usp/ep/jp grade.

Related News: In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 1,4-Dimethoxy-6-tetralone manufacturer On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks. 1,4-Dimethoxy-6-tetralone supplier In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 1,4-Dimethoxy-6-tetralone vendor In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 1,4-Dimethoxy-6-tetralone factory Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.